Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.881
https://www.valueinhealthjournal.com/article/S1098-3015(17)31215-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
843
First Page :
A554
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31215-9&doi=10.1016/j.jval.2017.08.881